Familial hypertrophic cardiomyopathy (FHC) is an inherited autosomal dominant disease characterized by ventricular hypertrophy and myofibrillar disarray. Sudden cardiac death, especially among young athletes, represents the most severe outcome of FHC in affected individuals (1-3). The genetic alterations have been localized to genes that encode various myofibrillar proteins (4, 5) . Among these, the β-myosin heavy chain (β-MHC) gene was the first to be implicated and remains the most common identified cause of FHC. Recently, a transgenic model of FHC in mice with truncated troponin T (TnT) has also been developed (6). These transgenic mice hearts are smaller than wild-type, with fewer myocytes, but they exhibit significant delay in relaxation in response to increased work load with mild systolic dysfunction. Despite these advances, it is not yet clear how the genetic lesions produce the characteristic phenotype.
Introduction
Familial hypertrophic cardiomyopathy (FHC) is an inherited autosomal dominant disease characterized by ventricular hypertrophy and myofibrillar disarray. Sudden cardiac death, especially among young athletes, represents the most severe outcome of FHC in affected individuals (1) (2) (3) . The genetic alterations have been localized to genes that encode various myofibrillar proteins (4, 5) . Among these, the β-myosin heavy chain (β-MHC) gene was the first to be implicated and remains the most common identified cause of FHC. Recently, a transgenic model of FHC in mice with truncated troponin T (TnT) has also been developed (6) . These transgenic mice hearts are smaller than wild-type, with fewer myocytes, but they exhibit significant delay in relaxation in response to increased work load with mild systolic dysfunction. Despite these advances, it is not yet clear how the genetic lesions produce the characteristic phenotype.
Few studies have attempted to investigate the functional abnormalities of hypertrophic cardiac muscles of FHC. Lin et al. (7) showed increased motility of thin filaments containing mutant TnT (TnT I91N), a lesion associated with FHC. Similarly, myotubes with truncated TnT (also implicated in FHC) produced less force (8) . Mutated myosin molecules also demonstrated decreased actin translocating activity (9) . Nevertheless, direct evidence of altered function in intact myocardium is sparse, and little is known about the pathophysiology of excitation-contraction coupling in FHC.
The recent introduction of an FHC mutation (Arg403Gln) into the mouse α-MHC gene has produced an animal model resembling, in many aspects, human FHC (10) . Here, we have studied the physiological properties of muscles from the hearts of these mice. The results indicate that there are alterations in excitation-contraction coupling in mutant mice, with lesions in myofilament contraction and associated changes of intracellular Ca 2+ ([Ca 2+ ] i ) handling.
Methods
Mouse muscle preparation. Adult male mice (Black Swiss strain, ∼20 weeks old, ∼35 g; for a detailed description of the mouse model of FHC, see ref. 10) were anesthetized by intra-abdominal injection of sodium pentobarbital (∼10-20 mg), and the hearts were rapidly excised via midsternal thoracotomy. As described for wild-type mice of another strain (11), the hearts were retrogradely perfused with modified Krebs-Henseleit (KH) buffer with high K + (20 mM) and gassed with a 95% O 2 /5% CO 2 gas mixture in a dissection dish at room temperature. Trabeculae or small papillary muscles (in mm: wild-type 0.90 ± 0.34 long, 0.18 ± 0.08 wide, and 0.11 ± 0.05 thick, n = 8; mutant 0.70 ± 0.21 long, 0.21 ± 0.10 wide, and 0.12 ± 0.04 thick, n = 8; mean ± SD) were quickly dissected from the right ventricle and mounted between a force transducer and a micromanipulator in a perfusion bath. The muscles were superfused with KH buffer equilibrated with 95% O 2 /5% CO 2 . The KH buffer was composed of (in mM): 142 Na + , 5 K + , 1. For the experiments to be technically successful, muscles must be long, thin, and nonbranching; such muscles are found only in ∼25% of mouse hearts (11) . [Ca 2+ ] i was measured with fura-2 potassium salt introduced iontophoretically into one cell and allowed to spread throughout the muscle via gap junctions as described previously (12) . Approximately 75% of microinjected muscles survived the loading protocol and remained stable in terms of force development and sarcomere pattern throughout the experimental protocol. Primarily because of the infrequency of geometrically suitable preparations, the overall success rate of getting a working muscle preparation was ∼15% (11). There was no difference in stability of the muscles or success rate between the two groups.
[Ca 2+ ] i was determined by measuring the epifluorescence of fura-2 in the cells excited using ultraviolet light at 380 nm and 340 nm. The fluorescent light was collected at 510 nm by a photomultiplier tube (R1527; Hamamatsu Instruments Co., Bridgeport, New Jersey, USA). The output of the photomultiplier tube was filtered at 100 Hz, collected by an A/D converter, and stored in the computer for later analysis.
[Ca 2+ ] i was given by the following equation (after subtraction of the autofluorescence of the muscle):
, where R is the observed ratio of fluorescence (340 nm/380 nm), K′ d is the apparent dissociation constant, R max is the ratio of 340 nm/380 nm at saturating [Ca 2+ ], and R min is the ratio of 340 nm/380 nm at zero [Ca 2+ ]. The values for K′ d , R max , and R min were taken from our previous study in mouse (11) .
Statistics. Student's t test and ANOVA were used for statistical analysis of the data (13, 14) . A value of P < 0.05 was considered to indicate significant differences between groups. Unless otherwise indicated, pooled data are expressed as mean ± SEM. 2+ ] o on twitch force. We first characterized force development and calcium cycling during twitch contractions. The pooled data in Fig. 2 confirm that the discrepancy between calcium cycling and force was consistent and significant. At any given [Ca 2+ ] o , more intracellular Ca 2+ is required in the mutant muscles to generate the same levels of force. As another way of gauging the relationship between [Ca 2+ ] i and force during twitch contractions, we plotted peak [Ca 2+ ] i against peak force in each muscle (Fig. 3) . Although there is no difference in the slopes (P = 0.2), the relationship from the mutant muscles is shifted to the right relative to the wild-type. Note also that the mutant muscles reach higher values of [Ca 2+ ] i during the generation of equivalent forces. These data clearly show that excitation-contraction coupling is abnormal in mutant myocardium. Moreover, the changes are distinctive, differing from those described previously in stunned myocardium (15) . 2+ ] o . We next looked for possible alterations in the time course of calcium and force during twitch contractions. Figure 4 plots the times to peak (a and b) and half-relaxation (c and d) for twitch force (a and c) and Ca 2+ transients (b and d). The times to peak force increased equivalently as [Ca 2+ ] o was raised in the two groups, whereas the times to peak [Ca 2+ ] i were not affected by changes in [Ca 2+ ] o in either the wild-type or mutant muscles. The only significant kinetic difference between the two groups was a delay of relaxation of force in the mutant muscles, evident at [Ca 2+ ] o >5 mM. Similar delays in relaxation have recently been reported in intact hearts from the same colony of mutant mice (16) .
Results
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Effect of stimulation frequency on [Ca 2+ ] i and force development. Mouse hearts normally contract at very high frequencies (>500/min at 37°C), whereas our baseline studies were performed at 0.5 Hz (20-22°C). To look for possible derangements in excitation-contraction coupling at higher frequencies, we increased the stimulation rate in a subset of the muscles to values as high as 4 Hz. As rate increased, [Ca 2+ ] i and force increased in both groups (Fig.  5, a and b) . Note, however, that the monotonic increase of force in the wild-type muscles contrasts with a secondary sag of force development at high frequencies in the mutants (Fig. 5b) . The mutants also exhibited a greater increase in diastolic force, despite the fact that no such differences were evident in diastolic [Ca 2+ ] i (Fig. 5a) . The differences are more obvious in Fig. 5, c and d Fig. 2 , there is a tendency for calcium transients to be larger at low frequencies in the mutants); in contrast, developed force diverged in the two groups at the higher stimulation rates, decreasing at frequencies >2 Hz in the mutants, but not in wild-type. Thus, contraction is impaired in mutant mice at higher stimulation rates.
Changes in steady-state force- [Ca 2+ ] i relationship. The changes in excitation-contraction coupling during twitch contractions include contributions from altered calcium cycling, but the relative importance and nature of myofilament involvement remain unclear. To evaluate myofilament Ca 2+ responsiveness directly, steady-state activation (Fig. 6a) was achieved by bursts of rapid pacing in the presence of cyclopiazonic acid (50 mM), a reversible inhibitor of calcium uptake by the sarcoplasmic reticulum. Figure 6b shows the pooled steady-state force-[Ca 2+ ] i relationships in the two groups. Several features of the activation curves are noteworthy. First, maximal Ca 2+ -activated force, or F max (48 ± 4.2 mN/mm 2 in wild-type, 45 ± 5.5 mN/mm 2 in mutant) is lower in both groups compared with muscles from younger mice of another strain (11) . An overall comparison of the curves from mutant and wild-type mice reveals significant differences (P = 0.03 by multivariate ANOVA). The midpoint of activation is similar in the mutant (Ca 50 = 1.35 ± 0.17 mM) and wild-type muscles (1.20 ± 0.07 mM; P > 0.05), but the slopes of the steady-state relationships are shallower in the mutants (5.30 ± 0.64 in wild-type vs. 2.94 ± 0.27 in mutant; P < 0.003). As a consequence of the decrease in slope without a change in the midpoint, force in the mutants tends to be greater at lower [Ca 2+ ] i , but the converse is true at higher [Ca 2+ ] i . In other words, at low [Ca 2+ ] i , mutant myofilaments are more sensitive to Ca 2+ , whereas at higher [Ca 2+ ] i , less force is produced until the two curves converge at F max . Similar behavior has been observed in skinned mutant muscles from this mouse model (17) .
Discussion
This is the first study of intact cardiac muscle in a mouse model of FHC. Our success in adapting the trabecular force/calcium measurement methodology for use in mouse cardiac muscle (11) enabled us to perform such a study. We have found that there are indeed alterations in the properties of the myofilaments in FHC mutant mice. As will be discussed later in this article, these changes have important implications for the pathophysiology of FHC.
Contraction and Ca 2+ transients in mutant muscles. One striking observation from this study was the increased Ca 2+ transient amplitude in mutant mice at higher (>3.0 2+ ] o , despite the fact that twitch force remained the same as in wild-type (Fig. 2) . This may intuitively lead one to believe that Ca 2+ responsiveness of mutant muscle is decreased, because more [Ca 2+ ] i was required to produce equivalent levels of force, as in stunned myocardium (15) . Nevertheless, several features of mutant muscles distinguish them phenotypically from stunned myocardium. First, FHC muscle exhibits the adaptive response of an increase in [Ca 2+ ] i to maintain force; i.e., more Ca 2+ is more mobilized. This may be due either to increased entry of Ca 2+ or increased release of Ca 2+ from the sarcoplasmic reticulum, or both. Second, the specific features of the decrease in Ca 2+ responsiveness in FHC mice are unique: when peak force and peak [Ca 2+ ] i were plotted against each other (Fig. 3) , there was no significant difference between the slopes of the relationships, but rather a parallel rightward shift of the relationship in mutant muscles. Obviously, a different mechanism than the one responsible for stunning is responsible for the decreased Ca 2+ responsiveness observed here. Primary alterations of cross-bridge cycling kinetics can be manifested as changes in steady-state myofilament Ca 2+ responsiveness (18) ; further studies will be required to ascertain the mechanism of these changes and their relationship to specific steps in cross-bridge cycling.
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Changes in relaxation of mutant muscles. In both groups of muscles, relaxation became slower as [Ca 2+ ] o was raised (Fig. 4) . This slowing of relaxation was apparently unrelated to [Ca 2+ ] i , because the decay of Ca 2+ transients was, paradoxically, accelerated. As discussed previously (11) , the delay of relaxation of force in the face of accelerated relaxation of Ca 2+ transients is likely the result of force-dependent changes in the affinity of the myofilaments to Ca 2+ at higher levels of force (19) . However, if an increase in the myofilament affinity for Ca 2+ were the sole mechanism, one would also expect higher peak force in mutant muscle, which was not observed. Increases in [Ca 2+ ] i have multiple effects that feed back upon relaxation. Phosphorylation of troponin I by Ca/calmodulin-dependent protein kinase II (CaMKII) decreases force development and accelerates relaxation (20) ; the kinase also increases Ca 2+ reuptake by the sarcoplasmic reticulum (21) . Although the idea is reasonable and merits further study, the possible involvement of protein kinase systems in the abnormal relaxation of mutant myocardium remains conjectural.
Effect of stimulation frequency in mutant muscles. Normal mouse cardiac muscle was found to have a positive force-frequency relationship (11) , and this feature was also observed in the wild-type muscles studied here (Fig.  5b) . The frequency-dependent potentiation of force was less pronounced in the present study, possibly owing to the use of older animals and/or to genuine differences between inbred mouse strains. In mutant muscles, diastolic force increased with stimulation frequency without concomitant changes of [Ca 2+ ] i . The increased diastolic force may simply reflect the previously discussed impairment of relaxation when Ca 2+ is high (Fig. 4) . On the other hand, the failure to produce higher systolic force presumably reflects a defect of force-generating ability of the mutant myofilaments, because Ca 2+ transients did not change. The negative force-frequency relationship provides a specific rationale for heart failure, especially during exercise. The delayed relaxation may underlie the diastolic dysfunction of FHC as well. (Fig. 6b) . This difference is mainly caused by a decrease in the cooperativity of the myofilaments. Because nor- mal mouse muscle has high myofilament cooperativity (Fig. 6b and ref. 11) , the decrease is expected to have a retarding effect on force development, especially when [Ca 2+ ] i is submaximal. Another alteration in the relationship worth noting is the cross-over with that of wild-type at ∼Ca 50 . As already discussed, this feature may be manifested as changes in relaxation dynamics (Fig. 4) . The mechanism for decreased cooperativity in mutant muscle is not understood at present, but it would not be surprising if it turns out to be a direct consequence of the structural alteration (Arg403Gln) in the myosin heavy chain.
While our findings reveal novel alterations of calcium cycling in FHC mutant muscle, the underlying mechanisms remain to be explored. Given the nature of the primary defect, these alterations may well be secondary to altered mechanics due to defective myofilament structure. We can clearly conclude that, for whatever reason, Ca 2+ mobilization is upregulated in FHC myocardium. These changes in Ca 2+ regulation may have numerous potential sequelae yet to be characterized. Given what we know about the key role of [Ca 2+ ] i in the pathogenesis of cardiac arrhythmias (22) , it seems probable that the higher incidence of sudden cardiac death in FHC with Arg403Gln mutation arises from the alterations in calcium cycling, rather than directly from the myofilament defect. In this respect, it would be very interesting to investigate whether changes in calcium cycling are less marked in muscles containing more benign mutations in myosin, e.g., Val606Met.
